PubMed:32586394 / 3247-3413
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T18 | 48-53 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T19 | 75-85 | Chemical | denotes | Enoxaparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30 | 0-166 | Sentence | denotes | Control Group (Low-Dose LMWH): patients in this group will be administered Enoxaparin (Inhixa®) at standard prophylactic dose (i.e., 4000 UI subcutaneously once day). |